Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen®: Single-Blind, Randomized, Crossover Trial.

Autor: Lubenau, Heinz1 heinz.lubenau@t-online.de, Bias, Peter2, Maly, Anne-Katrin1, Siegler, Karl Ernst3, Mehltretter, Kai4
Zdroj: BioDrugs. 2009, Vol. 23 Issue 1, p43-51. 9p. 5 Charts, 3 Graphs.
Databáze: Academic Search Ultimate